Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

NCT05806385 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DEVICE: Cryoablation
COMBINATION_PRODUCT: Cryoablation combined with PD1 Inhibitor

Sponsor

Texas Tech University Health Sciences Center